Loading...
Docoh

Tiziana Life Sciences (TLSA)

News

From Benzinga Pro
Tiziana Life Sciences Reports Initiation Of Phase 1b Trial For Crohn's
25 Mar 22
Biotech, News, FDA, General
This clinical trial, the first-ever oral immunotherapy for patients with mild-to-moderately active Crohn's Disease, is anticipated to be completed by Q4, 2022. NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Tiziana
TLSA: KOL Discussion and SPMS 6-Month Results
15 Mar 22
Penny Stocks
By John Vandermosten, CFA NASDAQ:TLSA Introduction
30 Stocks Moving in Friday's Pre-Market Session
11 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
78 Biggest Movers From Yesterday
11 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday.
Tiziana Life Shares Rise On Encouraging Data From Intranasal Foralumab In Multiple Sclerosis Patient
10 Mar 22
Biotech, News, Penny Stocks, Health Care, FDA, Movers, Trading Ideas, General
Tiziana Announces Clinical Data From Secondary Progressive Multiple Sclerosis Patient Treated For Six Months With Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
10 Mar 22
Biotech, General
Intranasal foralumab was well-tolerated with no adverse reactions or laboratory abnormalities after 6 months of therapy and the patient chose to remain on therapy Data show sustained inhibition
42 Stocks Moving in Monday's Pre-Market Session
7 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as crude surged to new highs.
80 Biggest Movers From Yesterday
2 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Stocks That Hit 52-Week Lows On Tuesday
22 Feb 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday's trading, 505 companies set new 52-week lows.

Press releases

From Benzinga Pro
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
26 Apr 22
News, Health Care, Press Releases
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ:TLSA) ("Tiziana" or the "Company"), a clinical-stage biopharmaceutical company developing alternative routes of
Tiziana Announces Availability of March 14 KOL Event Replay
15 Mar 22
Health Care, Press Releases, General
NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announces
Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis
11 Mar 22
News, Health Care, Press Releases
NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery,
Thinking about buying stock in Tiziana Life Sciences, Indonesia Energy, US Well Services, Kala Pharmaceuticals, or Nine Energy Service?
10 Mar 22
Opinion, Press Releases
NEW YORK, March 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TLSA, INDO, USWS, KALA, and NINE.
AccuStem Sciences, Inc. Appoints New Executive Leadership Team
4 Mar 22
News, Management, Press Releases
LONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC:ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, today announced the formation of its
StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort
1 Mar 22
Health Care, Press Releases
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.'s (NASDAQ:TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC:ACMSY) (formerly AccuStem Sciences Ltd.), today announced publication of new data